Policy
Injective’s INJ ETF approval opens regulated US access, but trading has not begun
The Cryptonomist·November 5, 2026·1 min read
Nasdaq approved Canary Capital's Staked INJ ETF listing on November 4, 2026, giving Injective's INJ token a route into the regulated US securities market with potential staking rewards. The Injective ETF approval marks an institutional milestone, but it is not the start of trading. Separately, INJ recovered to around $7.64.
Read at The CryptonomistDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.